Literature DB >> 15688692

TCM treatment of infectious atypical pneumonia--a report of 16 cases.

Xiaolin Tong1, Aiguo Li, Zhiyuan Zhang, Jun Duan, Xiaoguang Chen, Chuanjin Hua, Dong Zhao, Yuan Xu, Xiaoping Shi, Ping Li, Xin Tian, Fan Lin, Yongtong Cao, Lu Jin, Ming Chang, Yunting Wang.   

Abstract

OBJECTIVE: To probe into the mechanism on TCM treatment of infectious atypical pneumonia (severe acute respiratory syndrome, SARS) and evaluate its feasibility and effectiveness.
METHOD: Twelve TCM prescriptions of herbal drugs (orally or i.v.) were used to treat 16 cases of SARS without using glucocorticoids, anti-viral agents, immune-regulators or antibiotics (in case there was no definite bacterial infections). The symptoms, signs, chest roentgenograms and lab examinations were carefully monitored and recorded for evaluation of the effectiveness.
RESULTS: The average fever abatement time was 4.44 +/- 1.46 days and the mean absorption time of gross pulmonary infiltration was 10.87 +/- 2.92 days. No exacerbation occurred during the treatment.
CONCLUSION: TCM intervention could effectively control and alleviate the symptoms and prevent the disease from exacerbation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15688692

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  20 in total

1.  The long-term consequences of Corona Virus Disease 2019 patients receiving Chinese herbal medicine treatments in acute phase: A protocol for systematic review and meta-analysis.

Authors:  Yi-Ming Sun; Jia-Yan Liu; Ran Sun; Jie Zhang; Meng-Lu Xiao; Gui-Ping Li
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 2.  Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.

Authors:  Rachana Singh; Pradhyumna Kumar Singh; Rajnish Kumar; Md Tanvir Kabir; Mohammad Amjad Kamal; Abdur Rauf; Ghadeer M Albadrani; Amany A Sayed; Shaker A Mousa; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

3.  In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.

Authors:  Weifeng Yang; Jueling Liu; Biljana Blažeković; Yanan Sun; Shuhua Ma; Chuanyun Ren; Sanda Vladimir-Knežević; Chaohua Li; Yajun Xing; Guijie Tian; Yi Wang
Journal:  BMC Complement Altern Med       Date:  2018-05-30       Impact factor: 3.659

Review 4.  COVID-19 pandemic: A review based on current evidence.

Authors:  Vidya M Mahalmani; Dhruv Mahendru; Ankita Semwal; Sukhmeet Kaur; Harpinder Kaur; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020-06-03       Impact factor: 1.200

5.  Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Authors:  Namisha Sharma; Mehanathan Muthamilarasan; Ashish Prasad; Manoj Prasad
Journal:  Genomics       Date:  2020-07-24       Impact factor: 5.736

6.  What does it take to synergistically combine sub-potent natural products into drug-level potent combinations?

Authors:  Chu Qin; Kai Leng Tan; Cun Long Zhang; Chun Yan Tan; Yu Zong Chen; Yu Yang Jiang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

Review 7.  The potential contributions of traditional Chinese medicine to emergency medicine.

Authors:  Jun He; Xiang-Yu Hou
Journal:  World J Emerg Med       Date:  2013

8.  Chinese medicine for COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Huizhen Chen; Ziyan Xie; Yuxia Zhu; Qiu Chen; Chunguang Xie
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

Review 9.  The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

Authors:  Andréa D Fuzimoto; Ciro Isidoro
Journal:  J Tradit Complement Med       Date:  2020-05-30

Review 10.  Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Namrta Choudhry; Xin Zhao; Dan Xu; Mark Zanin; Weisan Chen; Zifeng Yang; Jianxin Chen
Journal:  J Med Chem       Date:  2020-09-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.